Medtronic beats quarterly profit estimates on robust demand for heart devices

Feb 17 (Reuters) - Medtronic surpassed Wall Street expectations for third-quarter nett connected Tuesday, buoyed by beardown request for ‌its bosom devices and diabetes monitors.

Medtech firms are benefiting ‌from surging request for aesculapian procedures arsenic wellness insurers study higher aesculapian nonaccomplishment ​ratios — an denotation that patients are availing much procedures. Market optimism is besides boosted by wider doc uptake and technological advances.

The institution maintained its fiscal 2026 adjusted per stock nett forecast astatine $5.62 to $5.66.

Medtronic’s ‌growth drivers see its ⁠pulsed tract ablation systems and its transcatheter aortic valve replacement devices, 2 minimally invasive technologies seeing ⁠rapid adoption.

Sales successful the company's cardiovascular segment, which accounts for astir 40% of sales, jumped 13.8% to $3.46 cardinal during the quarter, powered ​by beardown ​demand for its pulsed tract ​ablation portfolio.

The exertion uses ‌high-energy electrical pulses to destruct targeted bosom tissues to trim the frequence of abnormal bosom rhythms.

Medtronic competes with Abbott and Dexcom successful continuous glucose monitoring, a marketplace that has expanded arsenic patients progressively follow convenient digit prick-free technologies to way glucose levels.

Revenue ‌for the 3rd 4th came successful ​at $9.02 billion, compared with estimates of $8.91 billion, ​according to information compiled ​by LSEG.

On an adjusted basis, the institution reported ‌quarterly nett of $1.36 per share, ​beating analysts' mean ​estimate of $1.33 per share.

Healthcare conglomerate and larger adjacent Johnson & Johnson posted a 7.5% year-over-year summation successful medtech income successful ​the reported quarter, ‌driven by spot successful its electrophysiology conception that includes its ​heart devices.

(Reporting by Padmanabhan Ananthan and Puyaan Singh successful ​Bengaluru; Editing by Sahal Muhammed)